<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Cardiology/Hypertriglyceridemia/">
    <link rel="shortcut icon" href="../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Hypertriglyceridemia - MedNotes</title>
    <link href="../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../js/jquery-3.2.1.min.js"></script>
    <script src="../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Hypertriglyceridemia", url: "#_top", children: [
          ]},
          {title: "Background", url: "#background", children: [
          ]},
          {title: "Causes of HyperTG", url: "#causes-of-hypertg", children: [
          ]},
          {title: "Treatment", url: "#treatment", children: [
          ]},
          {title: "References", url: "#references", children: [
          ]},
        ];

    </script>
    <script src="../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Hypertrophic%20Cardiomyopathy/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Hypertrophic%20Cardiomyopathy/" class="btn btn-xs btn-link">
        Hypertrophic Cardiomyopathy
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Hypertension/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Hypertension/" class="btn btn-xs btn-link">
        Blood Pressure Thresholds and Targets for Pharm Therapy
      </a>
    </div>
    
  </div>

    

    <h1 id="hypertriglyceridemia">Hypertriglyceridemia</h1>
<h1 id="background">Background</h1>
<p>Triglyceride (TG) metabolism can produce a by-product called remnant lipoproteins, which can be atherogenic. Most guidelines consider hypertriglyceridemia to start at values â‰¥ 150 mg/dl. It is the most common dyslipidemia, as it can occur in 30% of the general population. Although fasting levels are usually obtained per the current US protocol, there is evidence that non-fasting TG levels might be a better indicator of cardiovascular (CV) risk as these levels may better reflect the usual levels that the body is exposed to.</p>
<h1 id="causes-of-hypertg">Causes of HyperTG</h1>
<ul>
<li>primary<ul>
<li>familial hyperTG</li>
<li>familial combined hyperlipidemia</li>
<li>familial dysbetalipoproteinemia</li>
<li>familial chylomicronemia</li>
<li>lipodystrophic syndromes</li>
</ul>
</li>
<li>secondary<ul>
<li>diet, decreased physical activity, smoking</li>
<li>diabetes, alcohol abuse, hypothyroidism, pregnancy</li>
<li>thiazides, non-selective beta blockers, antipsychotics, glucocorticoids</li>
<li>estrogen and estrogen receptor blockers</li>
<li>propofol</li>
<li>interferon</li>
<li>cancer therapies</li>
</ul>
</li>
</ul>
<h1 id="treatment">Treatment</h1>
<p><em>In summary, consider addition of EPA when triglycerides are still elevated on maximally tolerated statin therapy.</em> As well, address underlying possible causes of hyperTG as above.</p>
<ol>
<li><strong>JELIS (2007)</strong> - 19% relative risk reduction in cardiovascular events when 1.8g daily of eicosapentaenoic acid (EPA) was added to low-intensity statin therapy, for patients with hypercholesteremia and age 40-75</li>
<li><strong>REDUCE-IT (2018)</strong> - icosapent ethyl ester (EPA) led to a reduction in ASCVD events in secondary prevention patients and high risk primary prevention patients with DM and residual elevated TGs on top of maximally tolerated statin therapy</li>
<li><strong>STRENGTH (2021)</strong> - omega-3 CA (EPA+DHA) in addition to statin for patients with DLD and high ASCVD risk did NOT reduce MACE</li>
</ol>
<h1 id="references">References</h1>
<ol>
<li><a href="https://www.cardionerds.com/156-lipids-triglycerides-pathophysiology-to-clinical-outcomes-with-dr-matthew-budoff/">Triglycerides - Pathophysiology to Clinical Outcomes with Dr. Matthew Budoff</a></li>
<li><a href="https://www.cardionerds.com/207-lipids-reduce-it-versus-strength-trials-epa-in-clinical-practice-with-dr-peter-toth/">207. Lipids: REDUCE-IT Versus STRENGTH Trials - EPA in Clinical Practice with Dr. Peter Toth</a></li>
<li><a href="https://www.acc.org/latest-in-cardiology/clinical-trials/2010/02/23/19/10/jelis">Japan EPA Lipid Intervention Study - American College of Cardiology</a></li>
</ol>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Hypertrophic%20Cardiomyopathy/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Hypertrophic%20Cardiomyopathy/" class="btn btn-xs btn-link">
        Hypertrophic Cardiomyopathy
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Hypertension/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Hypertension/" class="btn btn-xs btn-link">
        Blood Pressure Thresholds and Targets for Pharm Therapy
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>